“AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability”. Explore Medical Science and Global Health, vol. 3, Oct. 2026, pp. 38-47, https://doi.org/10.70267/emsgh.v3.3847.